Clinical Trial

Accuracy of the Accuro 3S

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to evaluate the feasibility and accuracy of the Accuro 3S to provide live guidance when performing a neuraxial technique (e.g., spinal, or epidural). The Accuro 3S is a new device that was designed to allow for midline live neuraxial guidance. If the device can perform as the manufacturers claim the device will permit the performance of epidurals as close as doing them under fluoroscopy.
Trial Details
NCT Number NCT07458087
Lead Sponsor Yale University
Collaborators: Rivanna Medical, Inc.
Conditions Neuraxial Technique
Enrollment 50 participants
Start Date 2026-07-15
Primary Completion 2028-01-15 (estimated)
Study Completion 2028-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-09